Smithfield is taking a leadership position in developing these types of cutting edge initiatives, which support a range of biotechnology solutions in areas of human therapeutics, tissue fabrication and regenerative medicine.
«Our commitment to innovation and sustainability stretches across all aspects of our company," said Kenneth M. Sullivan, president and CEO of Smithfield Foods. «Smithfield Bioscience reflects these same values by finding new uses for byproducts that benefit the health and
Today, Smithfield sells byproducts to pharmaceutical and nutraceutical companies who use these materials to develop drugs that treat a range of issues, from indigestion, to hypothyroidism, to deep vein thrombosis. Smithfield Bioscience will expand upon these efforts by exploring new methods and technologies for addressing concerns such as tissue regeneration and the availability of viable human organs for transplantation. This dedicated team is solely focused on the responsible and transparent pursuit of these
One of Smithfield Bioscience’s first projects is the participation in the Advanced Regenerative Manufacturing Institute (ARMI), a
«Smithfield is a longstanding leader in sustainability and renewables with a broad geographic presence and strong manufacturing expertise," said Courtney Stanton, vice president of the new Bioscience Group for Smithfield Foods. «With these capabilities, our vertical integration and a reputation for transparency and quality, Smithfield Bioscience is
